Enyuan Shang

1.6k citations
27 papers · 1.2k indexed · h-index 17
Topics
Cancer, Hypoxia, and Metabolism (9 papers)Glioma Diagnosis and Treatment (6 papers)Protein Degradation and Inhibitors (6 papers)

In The Last Decade

Enyuan Shang

27 papers receiving 1.2k citations

Peers

Enyuan Shang
Comparison fields: 5 of 88
  • Molecular Biology 921
  • Cancer Research 201
  • Genetics 190
  • Genetics 118
  • Hematology 112
Replace Ivana Magnani with:
Ivana Magnani Italy
Lucia Cappabianca Italy
Nader Omidvar United Kingdom
Raudel Sandoval United States
Kyungsoo Ha United States
Dwight M. Morrow United States
Masaro Tashima Japan
Hans‐Christian Aasheim Norway
Fenghua Liu China
Weisheng Xu United States
Enyuan Shang relative to Ivana Magnani Italy Ivana Magnani's profile →
Citations per field
00.5×10×13.6×
Ivana Magnani · 1×
Citations per year

Countries citing papers authored by Enyuan Shang

Since Specialization
Citations

This map shows the geographic impact of Enyuan Shang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Enyuan Shang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Enyuan Shang more than expected).

Fields of papers citing papers by Enyuan Shang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Enyuan Shang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Enyuan Shang. The network helps show where Enyuan Shang may publish in the future.

Co-authorship network of co-authors of Enyuan Shang

This figure shows the co-authorship network connecting the top 25 collaborators of Enyuan Shang. A scholar is included among the top collaborators of Enyuan Shang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Enyuan Shang. Enyuan Shang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 3
3 7
4 2
5 76
6 140
7 8
8 13
9 2
10 44
11 58
12 43
13 15
14 59
15 24
16 124
17 203
18 93
19 5
20 90

About Enyuan Shang

Enyuan Shang is a scholar working on Cancer Research, Genetics and Biochemistry, having authored 27 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (9 papers), Glioma Diagnosis and Treatment (6 papers) and Protein Degradation and Inhibitors (6 papers). The work is most often cited by research in Molecular Biology (921 citations), Cancer Research (201 citations) and Genetics (118 citations). Enyuan Shang has collaborated with scholars based in United States, Germany and China. Frequent co-authors include Debra J. Wolgemuth, Xiangyuan Wang, Duancheng Wen, Georg Karpel‐Massler, Markus D. Siegelin, Trang Nguyen, Helen Nickerson, David A. Greenberg, Mike‐Andrew Westhoff and William S. Blaner. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026